Monday to Friday | 11 am to 8 pm
Saturday & Sun | 11 am to 6 pm
Closed on public holidays

Quick Facts:
Tirzepatide is a dual GIP/GLP-1 receptor agonist, administered as a once-weekly injection.
Price: From $600/month (2.5mg) up to $1,100/month (15mg)
Availability in Singapore: Available at Bay Aesthetics Clinic with a doctor's prescription following consultation
Medically reviewed by: Dr Hoe Ying Min, Medical Director, Bay Aesthetics Clinic
Last medically reviewed: July 2026

Tirzepatide is a medication used to treat type 2 diabetes and obesity. Tirzepatide is administered via subcutaneous injections (under the skin). Developed by Pharmaceutical company Eli Lilly, Tirzepatide is US FDA-approved for diabetes treatment, weight loss and treatment of obstructive sleep apnea. In Singapore, Tirzepatide was approved in 2023 by Health Sciences Authority (HSA) for the treatment of type 2 diabetes.
Mounjaro is the brand name Eli Lilly uses to market tirzepatide, the active ingredient covered throughout this page — the two terms describe the same medication, not two different drugs. Patients researching "Mounjaro Singapore" and those researching "Tirzepatide Singapore" are typically looking for identical information: dosing, side effects, and where the treatment is available locally.
In Singapore, Tirzepatide is HSA-approved under prescription for type 2 diabetes and is prescribed by doctors at Bay Aesthetics Clinic following an in-person consultation. Because Mounjaro Singapore availability is prescription-only, patients should be cautious of any source offering the medication without a doctor's assessment, regardless of whether it's advertised as Mounjaro or Tirzepatide.
Tirzepatide is a gastric inhibitory polypeptide (GIP) and Glucagon Like Peptide-1 (GLP-1) receptor agonist. After a meal, hormones known as GIP and GLP-1 are released by the gut. These hormones trigger insulin release, suppress appetite, slow gastric emptying, and increase satiety (the feeling of fullness). Tirzeptide mimics the hormones GIP and GLP-1 by activating the GIP and GLP-1 receptors that are present in the pancreas, brain, gut and fatty tissues.

The most common side effects include nausea, vomiting, diarrhea, decreased appetite, constipation, upper abdominal discomfort, and abdominal pain. These side effects are usually transient and improve with time. The dosage of Tirzepatide is gradually increased to reduce the severity of side effects.
Tirzepatide is indicated to improve blood sugar control in adult patients with type 2 diabetes.
Tirzepatide is indicated for the treatment of adult patients with obesity (BMI >30) or overweight with complications (BMI >27 with weight-related complications) and to treat moderate to severe obstructive sleep apnea in adults with obesity.
Tirzepatide and heart failure: In a phase III trial, tirzepatide has demonstrated significant benefits in obese patients with heart failure, reducing the risk of major complications, including urgent heart failure visits, hospitalisations, increased diuretic treatment, and cardiovascular-related deaths, by 38% compared to placebo.

In this landmark clinical trial published in the New England Journal of Medicine 2021, Tirzepatide was compared against Semaglutide. In this open-label, 40-week, phase 3 trial, 1879 patients were randomly assigned, in a 1:1:1:1 ratio, to receive tirzepatide at a dose of 5 mg, 10 mg, or 15 mg or semaglutide at a dose of 1 mg per week. At baseline, the mean glycated hemoglobin level was 8.28%, the mean age was 56.6 years, and the mean weight was 93.7 kg. The primary endpoint was the change in the glycated hemoglobin level from baseline to 40 weeks. Tirzepatide at all doses was noninferior and superior to semaglutide. Reductions in body weight were greater with tirzepatide than with semaglutide. The side effect profiles of both medications were similar.
SURMOUNT-1 Study: In this phase 3 double-blind, randomised, controlled trial, 2539 adult patients were assigned in a 1:1:1:1 ratio to receive once-weekly, subcutaneous tirzepatide (5 mg, 10 mg, or 15 mg) or placebo for 72 weeks, including a 20-week dose-escalation period. At baseline, the mean body weight was 104.8 kg, the mean BMI was 38.0, and 94.5% of participants had a BMI of 30 or higher. The mean percentage change in weight at week 72 was −15.0% with 5-mg weekly doses of tirzepatide, −19.5% with 10-mg doses, and −20.9% with 15-mg doses and −3.1% with placebo (P<0.001 for all comparisons with placebo). The percentage of participants who had weight reduction of 5% or more was 85%, 89%, and 91% with 5 mg, 10 mg, and 15 mg of tirzepatide, respectively, and 35% with placebo; 50% and 57% of participants in the 10-mg and 15-mg groups had a reduction in body weight of 20% or more, as compared with 3% in the placebo group (P<0.001 for all comparisons with placebo). The most common adverse events with tirzepatide were gastrointestinal, and most were mild to moderate in severity, occurring primarily during dose escalation. Adverse events caused treatment discontinuation in 4.3%, 7.1%, 6.2%, and 2.6% of participants receiving 5-mg, 10-mg, and 15-mg tirzepatide doses and placebo, respectively.

SURMOUNT 4 trial- Weight regain after stopping Tirzepatide (Mounjaro) after 36 weeks versus continuation of treatment

Tirzepatide is injected under the skin (subcutaneously) of your stomach (abdomen), thigh, or upper arm. Use Tirzepatide 1 time each week, at any time of the day.
Tirzepatide pens can last unrefrigerated for up to 21 days. Ensure the temperature of the medication stays below 30 °C. Avoid heat and direct sunlight
Remove the Pen from the refrigerator.
Leave the grey base cap on until you are ready to inject.
Check the Pen label to make sure you have the right medicine and dose and that it has not expired. Inspect the Pen to make sure that it is not damaged.
Make sure the medicine:
Choose your injection site: stomach or inner thigh
You will know your injection is complete when the grey plunger is visible.
After your injection, place the used Pen in a sharps container.

Tirzepatide comes in dosages of 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg. Each dose is once a week, starting at the lowest dose of 2.5mg and increasing gradually every 4 weeks till the effects of the medication are optimal or side effects become unbearable. A maximum dose of 15mg per week is allowed.




Tirzepatide is a prescription-only medication and can only be obtained from medical clinics with a doctor’s consultation and prescription. Tirzepatide can now be found in Singapore and is available in Bay Medical.
Patients seeking a comprehensive doctor-supervised weight management programme can also explore Bay Medical's tirzepatide treatment, where eligibility, treatment planning and ongoing follow-up are tailored to individual health goals.
We now have a supply of Tirzepatide (Mounjaro), which is available at Bay Medical Clinic.
The price of Tirzepatide:
Prices are in SGD, GST 9% applies.
The Mounjaro price in Singapore shown above reflects the monthly cost at each dose, but a full treatment course usually costs more than a single month's price because dosing is titrated upward over time. Following the schedule outlined earlier — starting at 2.5mg and increasing roughly every four weeks — a patient's Mounjaro price in Singapore will typically move through several of the tiers listed above before reaching a stable maintenance dose.
Based on Bay Aesthetics Clinic's published pricing, a patient progressing through the 2.5mg, 5mg, 7.5mg, 10mg and 15mg tiers would pay $600, $700, $900, $900 and $1,100 respectively at each stage, before GST. Because titration is adjusted individually by the prescribing doctor, the exact Mounjaro price in Singapore for any one patient can only be confirmed after a consultation, not from the price list alone.
Anyone comparing Mounjaro Singapore providers should check three things: whether the clinic requires an in-person medical consultation before prescribing, whether pricing is quoted nett or before GST, and whether the quoted Mounjaro price in Singapore includes the doctor's consultation fee or is medication-only. Bay Aesthetics Clinic's pricing, listed above, is nett per month per dose and requires a consultation with a prescribing doctor before treatment begins.
Because Tirzepatide (Mounjaro) is a prescription-only medication in Singapore, its price and availability can shift with manufacturer supply. Patients are advised to confirm current Mounjaro Singapore pricing and stock directly with the clinic rather than relying on older quotes found elsewhere online.
Tirzepatide (mounjaro) activates both GIP and GLP-1 receptors, rather than GLP-1 alone. In head-to-head trial data (SURPASS-2), this dual mechanism was associated with greater average weight loss and glycaemic control than a GLP-1-only comparator.
The added GIP pathway appears to enhance insulin sensitivity and satiety signalling beyond what GLP-1 activation alone achieves. Individual results still vary based on dose, adherence, and lifestyle factors.
Pricing depends on weekly dose: from $600/month at 2.5mg up to $1,100/month at 15mg (1 pen, 4 doses, GST applies). See the full pricing table on the page for all tiers.
Yes. Tirzepatide (mounjaro singapore) is approved by HSA for type 2 diabetes treatment and is available at Bay Aesthetics Clinic with a doctor's prescription following consultation.
Initial weight loss is often noticeable within 4–6 weeks, with more substantial results typically seen around 12 weeks, consistent with SURMOUNT-1 trial data.
While Tirzepatide (mounjaro) helps regulate appetite, combining treatment with a balanced diet and a caloric deficit (a 500kcal/day deficit is typically recommended) generally improves results.
Large clinical trials, including SURMOUNT-1, indicate Tirzepatide is generally safe for long-term use, with most side effects being mild-to-moderate gastrointestinal symptoms during dose escalation.
SURMOUNT-1 trial data showed mean weight reductions of 15.0% (5mg), 19.5% (10mg), and 20.9% (15mg) at 72 weeks, compared to 3.1% with placebo.
Switching between GLP-1/GIP medications is possible but should only be done under medical supervision, as dosing and titration schedules differ between medications.
No. Tirzepatide (mounjaro) is prescription-only. Purchasing from unauthorised online sources carries a real risk of counterfeit or unsafe products. Only obtain it through a licensed clinic following consultation.
Nausea, vomiting, diarrhoea, decreased appetite, constipation, and abdominal discomfort are most common, usually during the dose-escalation period, and typically improve with time.
Tirzepatide is a once-weekly subcutaneous injection, self-administered into the abdomen, thigh, or upper arm using a pre-filled pen.
2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg. Treatment starts at the lowest dose and is increased gradually every 4 weeks based on response and tolerability.
Yes. Tirzepatide is also indicated for type 2 diabetes and moderate-to-severe obstructive sleep apnoea in adults with obesity.
At Bay Aesthetics Clinic, the Mounjaro price in Singapore starts from $600 nett per month at the 2.5mg starting dose, rising to $1,100 nett per month at the 15mg maintenance dose (GST applies). See the pricing table above for all tiers — your exact price is confirmed only after a doctor's consultation, since your starting dose depends on individual assessment.
Mounjaro (tirzepatide) is prescription-only in Singapore and cannot be bought over the counter or online. Buying Mounjaro Singapore stock legitimately means booking a consultation at a licensed clinic — Bay Aesthetics Clinic at Marina Bay Link Mall offers this following an in-person assessment with a prescribing doctor.

With over 10 years of experience in aesthetic treatments, Dr Hoe Ying Min serves as the Medical Director at Bay Aesthetics Clinic. She has extensive hands-on experience in lasers, injectables, body-shaping and skin-rejuvenation procedures, and is known for her careful, personalised approach that aims for natural-looking outcomes.

Bay Aesthetics Clinic and Medispa is a doctor-led clinic located in the Marina Bay Financial Centre that delivers medical aesthetics and medispa treatments in a calm, professional setting. With a focus on safety, visible results and accessibility, the team uses only US FDA and approved technology, applies a holistic view to beauty and wellness, and avoids hard-selling or pressure tactics.
Open from 11 am daily (until 8 pm Mon-Fri; 6 pm Sat/Sun) and conveniently situated within walking distance of two MRT stations